Lymph node ratio is an independent prognostic factor in patients with rectal cancer treated with preoperative chemoradiotherapy and curative resection

European Journal of Surgical Oncology

Volumn 38, Issue 6, 2012, Pages 478-483

  Lee, S D ^a,b   Kim, T H ^a   Kim, D Y ^a   Baek, J Y ^a   Kim, S Y ^a   Chang, H J ^a   Park, S C ^a   Park, J W ^a   Oh, J H ^a   Jung, K H ^c  

^a National Cancer Center   (South Korea)

^b Daehang Hospital   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

Author keywords

Chemoradiotherapy; Lymph node; Lymph node ratio; Preoperative; Rectal cancer

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURGERY; CHEMORADIOTHERAPY; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RECTUM CANCER;

ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY, ADJUVANT; CONFOUNDING FACTORS (EPIDEMIOLOGY); DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECTAL NEOPLASMS; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84860298924     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2012.03.002     Document Type: Article

References (26)

1. F.L. Greene, A.K. Stewart, and H.J. Norton A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50,042 patients Ann Surg 236 2002 416 421
2. D.G. Haller, P.J. Catalano, and J.S. Macdonald Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089 J Clin Oncol 23 2005 8671 8678 (Pubitemid 46211510)
3. H.T. Arkenau, A. Bermann, K. Rettig, G. Strohmeyer, and R. Porschen 5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial Ann Oncol 14 2003 395 399 (Pubitemid 36367416)
4. A.C. Berger, E.R. Sigurdson, and T. LeVoyer Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes J Clin Oncol 23 2005 8706 8712 (Pubitemid 46211514)
5. Y.S. Kim, J.H. Kim, and S.M. Yoon Lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy Int J Radiat Oncol Biol Phys 74 2009 796 802
6. A. Marchet, S. Mocellin, and A. Ambrosi The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients Ann Surg 245 2007 543 552 (Pubitemid 46555657)
7. C. Mariette, G. Piessen, N. Briez, and J.P. Triboulet The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent Ann Surg 247 2008 365 371 (Pubitemid 351156783)
8. I.J. Park, G.S. Choi, and S.H. Jun Nodal stage of stage III colon cancer: the impact of metastatic lymph node ratio J Surg Oncol 100 2009 240 243
9. T.M. Pawlik, A.L. Gleisner, and J.L. Cameron Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer Surgery 141 2007 610 618 (Pubitemid 46616937)
10. F. Peschaud, S. Benoist, and C. Julie The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer Ann Surg 248 2008 1067 1073
11. R. Rosenberg, J. Friederichs, and T. Schuster Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period Ann Surg 248 2008 968 978
12. M.B. Slidell, D.C. Chang, and J.L. Cameron Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis Ann Surg Oncol 15 2008 165 174
13. P. Das, J.M. Skibber, and M.A. Rodriguez-Bigas Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer Am J Clin Oncol 29 2006 219 224 (Pubitemid 44270928)
14. H.Y. Lee, H.J. Choi, and K.J. Park Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma Ann Surg Oncol 14 2007 1712 1717
15. N.N. Baxter, A.M. Morris, D.A. Rothenberger, and J.E. Tepper Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: a population-based analysis Int J Radiat Oncol Biol Phys 61 2005 426 431 (Pubitemid 40164437)
16. S.G. de la Fuente, R.J. Manson, K.A. Ludwig, and C.R. Mantyh Neoadjuvant chemoradiation for rectal cancer reduces lymph node harvest in proctectomy specimens J Gastrointest Surg 13 2009 269 274
17. C.C. Thorn, N.P. Woodcock, N. Scott, C. Verbeke, S.B. Scott, and N.S. Ambrose What factors affect lymph node yield in surgery for rectal cancer? Colorectal Dis 6 2004 356 361 (Pubitemid 39236535)
18. H. Wang, B. Safar, S. Wexner, R. Zhao, M. Cruz-Correa, and M. Berho Lymph node harvest after proctectomy for invasive rectal adenocarcinoma following neoadjuvant therapy: does the same standard apply? Dis Colon Rectum 52 2009 549 557
19. B. Morcos, B. Baker, M. Al Masri, H. Haddad, and S. Hashem Lymph node yield in rectal cancer surgery: effect of preoperative chemoradiotherapy Eur J Surg Oncol 36 2010 345 349
20. H. Nelson, N. Petrelli, and A. Carlin Guidelines 2000 for colon and rectal cancer surgery J Natl Cancer Inst 93 2001 583 596 (Pubitemid 32409626)
21. L. Stocchi, H. Nelson, and D.J. Sargent Impact of surgical and pathologic variables in rectal cancer: a United States community and cooperative group report J Clin Oncol 19 2001 3895 3902 (Pubitemid 32880068)
22. J.W. Dekker, K.C. Peeters, H. Putter, A.L. Vahrmeijer, and C.J. van de Velde Metastatic lymph node ratio in stage III rectal cancer; prognostic significance in addition to the 7th edition of the TNM classification Eur J Surg Oncol 36 2010 1180 1186
23. D. Edler, K. Ohrling, M. Hallstrom, M. Karlberg, and P. Ragnhammar The number of analyzed lymph nodes - a prognostic factor in colorectal cancer Acta Oncol 46 2007 975 981 (Pubitemid 47537177)
24. J. Kang, H. Hur, B.S. Min, K.Y. Lee, and N.K. Kim Prognostic impact of the lymph node ratio in rectal cancer patients who underwent preoperative chemoradiation J Surg Oncol 104 2011 53 58
25. C.L. Klos, L.G. Bordeianou, P. Sylla, Y. Chang, and D.L. Berger The prognostic value of lymph node ratio after neoadjuvant chemoradiation and rectal cancer surgery Dis Colon Rectum 54 2011 171 175
26. J. Wang, J.M. Hassett, M.T. Dayton, and M.N. Kulaylat Lymph node ratio: role in the staging of node-positive colon cancer Ann Surg Oncol 15 2008 1600 1608